...
机译:一种新的Moyamoya病,肾发育不全性,氨基转移酶升高和与RNF213相关的脱诺变种相关的皮肤病综合征
Childrens Hosp Philadelphia Div Human Genet Philadelphia PA 19104 USA;
Auckland Dist Hlth Board Starship Childrens Hlth Pediat Neuroserv Auckland New Zealand;
Childrens Hosp Philadelphia Dept Pediat Div Neurol Philadelphia PA 19104 USA;
Auckland Dist Hlth Board Starship Child Hlth Dept Pediat Gastroenterol Auckland New Zealand;
Childrens Hosp Philadelphia Div Gastroenterol Hepatol &
Nutr Philadelphia PA 19104 USA;
Childrens Hosp Philadelphia Div Gastroenterol Hepatol &
Nutr Philadelphia PA 19104 USA;
Childrens Hosp Philadelphia Dept Pediat Div Nephrol Philadelphia PA 19104 USA;
Auckland Dist Hlth Board Starship Child Hlth Dept Pediat Nephrol Auckland New Zealand;
Childrens Hosp Philadelphia Div Human Genet Philadelphia PA 19104 USA;
Childrens Hosp Philadelphia Dept Radiol Div Intervent Radiol Philadelphia PA 19104 USA;
Childrens Hosp Philadelphia Ctr Appl Genom Philadelphia PA 19104 USA;
Childrens Hosp Philadelphia Ctr Appl Genom Philadelphia PA 19104 USA;
Childrens Hosp Philadelphia Ctr Appl Genom Philadelphia PA 19104 USA;
Childrens Hosp Philadelphia Ctr Appl Genom Philadelphia PA 19104 USA;
Childrens Hosp Philadelphia Ctr Appl Genom Philadelphia PA 19104 USA;
Childrens Hosp Philadelphia Div Human Genet Philadelphia PA 19104 USA;
elevated aminotransferases; erythema multiforme; kidney dysplasia; moyamoya disease; RNF213;
机译:从头发生RNF213变异的婴儿的烟雾病的非典型表现
机译:De Novo开发Moyamoya疾病在成年女性中,RNF-213基因的遗传变异:案例报告
机译:综合征先天性心脏病患者鉴定的新型PBX1 de novo畸形变异的功能表征
机译:欧洲Moyamoya病和Moyamoya综合征的血管造影结果
机译:评估非洲人和欧洲人对2型糖尿病相关的终末期肾脏疾病和相关表型易感性的遗传变异。
机译:新生的RNF213变异婴儿的Moyamoya病的非典型表现
机译:一种新的Moyamoya疾病综合征,肾发育不良,氨基转移酶升高以及与RNF213中的德诺伊族变异相关的皮肤病
机译:快速进入上市前批准和De Novo医疗器械用于未满足医疗需要的生命威胁或不可逆转的衰弱疾病或条件:工业和食品药品管理局工作人员指南。